Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47627-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Compliance of Patients With Locally Advanced Colorectal Cancer to Chemotherapy Using FOLFOX Compared to XELOX Regimen

The New Ropanasuri Journal of Surgery
2016English

Efficacy and Safety of XELOX and FOLFOX6 Adjuvant Chemotherapy Following Radical Total Gastrectomy

Oncology Letters
Cancer ResearchOncology
2012English

Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2018English

GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Use of a Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients With Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer

Scientific Reports
Multidisciplinary
2019English

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched With Patients Treated With Parenteral Chemotherapy

Anticancer Research
MedicineCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy